It's a pure high-risk gamble. There is no way to predict the future on this one. As I expect to gain decent profits in the short run on my ABQ$ stock (movie business with a small percent of the royalties of the upcoming Taylor Swift movie distribution in China), I'll use that money to take a much more significant risk here. Even though I like how it appears insiders and associates are collecting shares via preferred stock conversions, anything goes with these OTC stocks.
I've been in OTC stocks that looked fabulous, only to have them hit me with multiple 1:1000 reverse splits, losing everything. And I've had other stocks that looked like complete trash with massive dilution, yet fabulous BS stories made them run 100x, after I had sold out in advance of course. One company, RXMD, uplisted to Nasdaq, continues to post growing revenue in the tens of millions of dollars annually, but since they always manage to overspend, or whatever, they never can show a decent profit so the stock just sits there, year after year.
If I get the profits I expect from my other stock, I don't mind taking a significantly higher risk, even if I lose it all. I like having at least one super-high-risk stock, especially in the beverage business. I wasn't patient enough with the Celsius beverage stock (CELH). I was new to the OTC back then and sold it around $1.50, right before it started making it's long term move up the chart. I've learned to be more patient and not just chase quick-flip momentum stocks that have no real products. Though our issue is still excessive and growing dilution, the only thing I've ever seen cure that is massive revenue and profits which I hope we see in the future. It's very high risk and certainly not investment advice.
